McCann wins Oxycontin brief

SINGAPORE - Mundipharma has appointed McCann Healthcare Worldwide to develop a regional branding platform for Oxycontin, an opiate-based painkiller for cancer.

by Staff Reporters

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Register now

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features

Join now